Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infection
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- A novel approach to generate a recombinant toxoid vaccine against Clostridium difficileMicrobiology, 2013
- Novel High-Molecular-Weight, R-Type Bacteriocins of Clostridium difficileJournal of Bacteriology, 2012
- A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2012
- A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile InfectionInfection and Immunity, 2012
- Efficacy of LFF571 in a Hamster Model of Clostridium difficile InfectionAntimicrobial Agents and Chemotherapy, 2012
- Current State of Clostridium difficile Treatment OptionsClinical Infectious Diseases, 2012
- Immunization with Bacillus Spores Expressing Toxin A Peptide Repeats Protects against Infection with Clostridium difficile Strains Producing Toxins A and BInfection and Immunity, 2011
- Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficileProceedings of the National Academy of Sciences, 2010
- Morphological and Genetic Diversity of Temperate Phages in Clostridium difficileApplied and Environmental Microbiology, 2007
- Bacillus cereus and its food poisoning toxinsFEMS Microbiology Letters, 2006